MassMEDIC — the trade group for New England’s medical device industry hub — has a new board chair and an expanded roster of board members as it prepares for its 30th anniversary in 2026.

The group announced on June 18 that Minerva Surgical CEO Todd Usen will serve as board chair, leading a larger board — and an expanded executive committee with executives representing Abiomed, Best Buy Medical, Podimetrics, Spryte Medical, Teleflex and KPMG.

Usen is a well-known executive in the medical device industry. He took over as CEO of Minerva Surgical — which has developed technology to treat heavy periods — in early 2023. Before that, he served for four years as CEO at Activ Surgical. The previous three years, he was president of Olympus’ Medical Systems Group. Other roles during his career have included executive positions at Smith+Nephew and Boston Scientific.

“Mr. Usen has been involved with MassMEDIC for more than five years and is an innovative industry leader with a well-known track record of developing and growing valuable medtech solutions,” MassMEDIC President Brian Johnson said in a news release.

“We are excited he is at the helm of our Board of Directors that has been crafted to meet this moment in medtech — and continue on the growth trajectory our organization has seen over the last five years — with an emphasis on diverse voices, including more policy and payment experts to help us close one of our industry’s most critical gaps. I would also like to thank our immediate past chair, Mary Anne Heino, former CEO of Lantheus, for her leadership and contribution to patient care in Massachusetts and beyond.”

Usen described the MassMEDIC board as a dynamic team of industry leaders. “For nearly 30 years, the organization has provided imperative services to medical technology organizations and I’m eager to harness our vast talent and combined dedication to the industry to continue to elevate the organization in the years to come.”

The board of directors also has two new executive committee members: Diana Gelston, chief commercial officer of Best Buy Health, and Devi Govender, platform president and Johnson & Johnson MedTech’s Abiomed.

New board members include:

• Desmond Adler, PhD, president, Gentuity;
• Matthew Boyd, chief commercial officer, Boyd Biomedical;
• Robert Chisena, PhD, co-founder and CTO, Amplitude Vascular Systems;
• Rebecca Fahrig, head of business nine EVR and VP of innovation at Siemens Healthineers’ Business Area Advanced Therapies;
• Michael Ferguson, PhD, VP of global healthcare economics and reimbursement, AtriCure;
• Nan-Wei Gong, PhD, founder and CEO, FIGUR8;
• Devi Govender, platform president, J&J’s Abiomed;
• Anh Hoang-Lindsay, PhD, CEO, Jana Care;
• Rajit Kamal, VP and GM, surgical robotics, Medtronic;
• Julie Khani, corporate VP, government affairs and corporate communications, Hologic;
• Michael E. Lyman, VP, sales and marketing, Karl Storz;
• Mary Beth Moynihan, SVP, market access and chief marketing officer, Boston Scientific;
• Stephanie Nelson Wimmer, MBA, MPH, global VP, health economics, market access and reimbursement (HEMAR), Philips;
• Alexander Rodero, SVP, finance, Werfen;
• Carolina Säve, of counsel, Minz.

“Having the commitment of these experienced industry leaders on our board of directors is a true testament to the strength of our medtech ecosystem,” said Rachel Robinson, COO of MassMEDIC. “Their dedication to improving lives through medical technology further strengthens our mission to bolster the New England medical technology community through connection, education, awareness and advocacy. With their expertise, we look forward to continued growth of the organization in support of our members and the New England region becoming a global beacon for medical technology.”